Published in Infect Immun on October 01, 2005
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun (2005) 1.13
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo. Infect Immun (2009) 1.07
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
A history of the development of Brucella vaccines. Biomed Res Int (2013) 0.97
Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol (2007) 0.94
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One (2011) 0.93
Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity. J Immunol (2009) 0.88
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella. J Immune Based Ther Vaccines (2009) 0.84
Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice. Infect Immun (2011) 0.84
Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection. Vet Res (2014) 0.83
In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate. Iran J Basic Med Sci (2014) 0.82
Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins. Iran J Microbiol (2013) 0.82
Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria. Clin Vaccine Immunol (2007) 0.81
Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge. Immunol Cell Biol (2016) 0.79
Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge. Genet Vaccines Ther (2010) 0.78
Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection. Virol J (2014) 0.77
Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs. Clin Vaccine Immunol (2014) 0.76
Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice. Clin Vaccine Immunol (2014) 0.76
Meta-Analysis and Advancement of Brucellosis Vaccinology. PLoS One (2016) 0.75
MicroRNA Expression Patterns of CD8+ T Cells in Acute and Chronic Brucellosis. PLoS One (2016) 0.75
Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies. BMC Microbiol (2017) 0.75
Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine. Rep Biochem Mol Biol (2013) 0.75
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis (1997) 9.69
An overview of human brucellosis. Clin Infect Dis (1995) 5.30
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol (1996) 2.96
Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol (1989) 2.73
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Immunology. Licence to kill. Nature (1998) 2.34
Brucellosis vaccines: past, present and future. Vet Microbiol (2002) 2.25
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev (2003) 2.03
Mechanisms influencing the immunodominance of T cell determinants. J Exp Med (1988) 1.91
CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur J Immunol (1995) 1.75
Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology (2001) 1.74
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine (1996) 1.70
Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res (2004) 1.68
Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol (2002) 1.65
Immunity and protection against Brucella abortus. Microbes Infect (2001) 1.50
Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein. Infect Immun (1996) 1.49
The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol (1997) 1.46
DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol (2000) 1.42
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun (1994) 1.35
Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella. J Med Microbiol (1991) 1.34
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun (2001) 1.33
Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine (1994) 1.32
Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet (1993) 1.25
Demonstration of peptidoglycan-associated Brucella outer-membrane proteins by use of monoclonal antibodies. J Gen Microbiol (1992) 1.24
Antibody response to Brucella outer membrane proteins in bovine brucellosis: immunoblot analysis and competitive enzyme-linked immunosorbent assay using monoclonal antibodies. J Clin Microbiol (1992) 1.22
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun (2001) 1.19
Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect Immun (2000) 1.11
A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2003) 1.11
Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies. Microbes Infect (2000) 1.11
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes Infect (2003) 1.10
Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J Med Microbiol (2002) 1.07
The regulation of CD95 ligand expression and function in CTL. J Immunol (1998) 1.06
Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol (2000) 1.06
Immune control of Brucella abortus 2308 infections in BALB/c mice. FEMS Immunol Med Microbiol (2001) 1.06
Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun (2001) 1.05
Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae. Clin Diagn Lab Immunol (2004) 1.05
Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J Med Microbiol (1992) 1.04
Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun (1998) 1.03
Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis. J Med Microbiol (1995) 1.01
Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice. Vaccine (1999) 1.00
Persistence of Brucella abortus in the livers of T cell-deficient nude mice. Lab Invest (1995) 0.99
Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine (1997) 0.98
Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Infect Immun (2004) 0.96
Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams. Vet Microbiol (1987) 0.92
Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine (2002) 0.91
Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol (2000) 0.89
Plasmid DNA vaccines are effective in the absence of IFNgamma. Virology (1999) 0.87
A laboratory reference vaccine to titrate immunogenic activity of antibrucella vaccines in mice. Ann Rech Vet (1983) 0.87
Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams. Res Vet Sci (1990) 0.87
Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120. Clin Exp Immunol (1997) 0.85
Economics of Brucella ovis control in sheep: epidemiologic simulation model. J Am Vet Med Assoc (1987) 0.83
Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol (2005) 0.83
Effectivity of Rev 1 vaccine in rams against brucella ovis infection. J S Afr Vet Assoc (1975) 0.81
Protective CTL response is induced in the absence of CD4+ T cells and IFN-gamma by gene gun DNA vaccination with a minigene encoding a CTL epitope of Listeria monocytogenes. Vaccine (2001) 0.81
Cytotoxic T cells and mycobacteria. FEMS Microbiol Lett (2001) 0.81
Protection of interferon-gamma knockout mice against Listeria monocytogenes challenge following intramuscular immunization with DNA vaccines encoding listeriolysin O. Vaccine (2003) 0.81
Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses. J Allergy Clin Immunol (2009) 2.78
Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation. Proc Natl Acad Sci U S A (2004) 2.74
Sedimentation velocity analysis of heterogeneous protein-protein interactions: Lamm equation modeling and sedimentation coefficient distributions c(s). Biophys J (2005) 2.39
Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol (2004) 1.52
Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients. Clin Experiment Ophthalmol (2006) 1.13
Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect (2011) 1.13
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun (2005) 1.13
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J Infect Dis (2002) 1.09
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun (2003) 1.06
Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae. Clin Diagn Lab Immunol (2004) 1.05
A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice. Infect Immun (2006) 1.05
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun (2008) 1.04
Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect Immun (2007) 0.99
Spontaneous or Mycobacterium tuberculosis-induced apoptotic neutrophils exert opposite effects on the dendritic cell-mediated immune response. Eur J Immunol (2007) 0.98
Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis. PLoS Pathog (2012) 0.98
Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am J Pathol (2010) 0.96
Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun (2009) 0.95
Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide. Mol Genet Metab (2013) 0.95
Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect Immun (2008) 0.94
Suture rupture in acromioclavicular joint dislocations treated with flip buttons. Arthroscopy (2011) 0.94
Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol (2007) 0.94
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One (2011) 0.93
Brucella outer membrane protein Omp31 is a haemin-binding protein. Microbes Infect (2006) 0.91
Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus. Infect Immun (2010) 0.91
Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine (2002) 0.91
Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis. Clin Diagn Lab Immunol (2002) 0.91
Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infect Immun (2011) 0.91
Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α. Gene (2012) 0.90
Characteristics and role of the exocellular polysaccharides produced by five cyanobacteria isolated from phototrophic biofilms growing on stone monuments. Biofouling (2012) 0.90
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine (2009) 0.90
NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Immunology (2005) 0.90
Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-α production. J Leukoc Biol (2011) 0.90
Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death. Microbes Infect (2009) 0.89
Paradoxical role of CD16+CCR2+CCR5+ monocytes in tuberculosis: efficient APC in pleural effusion but also mark disease severity in blood. J Leukoc Biol (2011) 0.89
BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis. Infect Immun (2013) 0.89
Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One (2012) 0.89
Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice. Infect Immun (2013) 0.88
Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect (2008) 0.87
Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol Cell Biol (2010) 0.86
Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses. Cell Microbiol (2012) 0.85
Immunopathology of Brucella infection. Recent Pat Antiinfect Drug Discov (2013) 0.84
Impaired dendritic cell differentiation of CD16-positive monocytes in tuberculosis: role of p38 MAPK. Eur J Immunol (2013) 0.84
Differential composition of culture supernatants from wild-type Brucella abortus and its isogenic virB mutants. Arch Microbiol (2009) 0.84
Microbial diversity in paleolithic caves: a study case on the phototrophic biofilms of the Cave of Bats (Zuheros, Spain). Microb Ecol (2010) 0.84
Brucella-infected hepatocytes mediate potentially tissue-damaging immune responses. J Hepatol (2010) 0.83
A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination. Vaccine (2007) 0.83
Direct and monocyte-induced innate immune response of human lung epithelial cells to Brucella abortus infection. Microbes Infect (2010) 0.83
Prepatellar bursitis due to Brucella abortus: case report and analysis of the local immune response. J Med Microbiol (2010) 0.83